Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Benedict16thon Nov 15, 2020 3:51pm
107 Views
Post# 31903596

RE:RE:Financials ...

RE:RE:Financials ...Excuses ..excuses, they have been looking for new drug deals for six Year with lots of cash at hand. What did they get in new drugs? Not much but they did buy GBT and for one year only one new drug. GBT sells about 40 Million a quarter but no profit/revenues. As for people not buying because of coid-19 is nonsense as other pharma sells are up. They bought GBT so they can at best breakeven? A real genius investment move is it not? Buffet could not find much in terms M&A for the hoard of cash so he invested directly and bought dozens of different company shares such as apple, JPM and others. GUD bought GBT, no profit but they sold PRN a pearl of a company. Maybe  GUD MNGT should be replaced by PRN mngt. There is a good idea. In business do not blame others when you are failing and do not wander but look what others are doing and what you are not doing.  Meir/Medison was he a bad investor? Really bad for investor according to GUD MNGT, yet he was paying GUD a nice dividend for five Years. Has GUD made a profit and or paid investors a dividend? Nothing, nada and they lost 45% market capitalization. So, in retrospect, almost two Years later, who is really bad? We do not know for sure about how Medison is doing but we sure hell know how bad GUD has done for two Years. Meir come back please and help shareholders. We beg you.
How could they even imagine for shareholders to be happy? How can they stay and continue manage ? Do they not see the numbers? Yet they saw the number with Paladin, and they keep talking about it. Why?   One shambled billion dollar and unable to get new good drugs and or M&A and a decent return on one billion dollars. This GUD MNGT needs to resign or forced to as GUD has been an historical fiasco.  
Bullboard Posts